OS Therapies Incorporated (OSTX) is a publicly traded Healthcare sector company. As of July 2, 2026, OSTX trades at $1.84 with a market cap of $84.62M and a P/E ratio of -1.86. OSTX moved +1.66% today. Year to date, OSTX is +35.07%; over the trailing twelve months it is -6.22%. Its 52-week range spans $1.12 to $7.00. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces OSTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for OSTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.84 |
| Market Cap | $84.62M |
| P/E Ratio | -1.86 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.00 |
| 52-Week Low | $1.12 |
| Volume | 393.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.75M |
| Gross Margin | 0.00% |
2 analysts cover OSTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.